We have demonstrated previously that Rheb1 is essential for myelination in the CNS using a Nestin-Cre driver line that deletes Rheb1 in all neural cell lineages, and recent studies using oligodendrocyte-specific CNP-Cre have suggested a preferential role for mTORC1 is myelination in the spinal cord. Here, we examine the role of Rheb1/mTORC1 in mouse oligodendrocyte lineage using separate Cre drivers for oligodendrocyte progenitor cells (OPCs) including Olig1-Cre and Olig2-Cre as well as differentiated and mature oligodendrocytes including CNP-Cre and Tmem10-Cre. Deletion of Rheb1 in OPCs impairs their differentiation to mature oligodendrocytes. This is accompanied by reduced OPC cell-cycle exit suggesting a requirement for Rheb1 in OPC differentiation. The effect of Rheb1 on OPC differentiation is mediated by mTor since Olig1-Cre deletion of mTor phenocopies Olig1-Cre Rheb1 deletion. Deletion of Rheb1 in mature oligodendrocytes, in contrast, does not disrupt developmental myelination or myelin maintenance. Loss of Rheb1 in OPCs or neural progenitors does not affect astrocyte formation in gray and white matter, as indicated by the pan-astrocyte marker Aldh1L1. We conclude that OPC-intrinsic mTORC1 activity mediated by Rheb1 is critical for differentiation of OPCs to mature oligodendrocytes, but that mature oligodendrocytes do not require Rheb1 to make myelin or maintain it in the adult brain. These studies reveal mechanisms that may be relevant for both developmental myelination and impaired remyelination in myelin disease.
Introduction
The myelination of axons by oligodendrocytes (OLs) in the brain is essential for rapid saltatory transduction of neuronal impulses along neural networks, and is regulated by both developmental (Emery, 2010) and activity-dependent mechanisms (Fields and Stevens-Graham, 2002) . The formation of myelin in the brain requires mature, myelinating OLs, which provide essential signals for radial growth of axons, as well as metabolic support to axons to maintain their long-term structural integrity (Lee et al., 2012) . OLs are derived from oligodendrocyte precursor cells (OPCs) that are identified by expression of PDGFR␣ and NG2 proteoglycan (Rivers et al., 2008) . OPCs exit the cell cycle, becoming postmitotic OLs that further mature into late-stage, myelinating OLs. The maturation of OLs can be monitored by the expression of cellular markers for mature OLs including, adenomatous polyposis coli, also known as CC1, proteolipid protein (PLP) and Tmem10, aka Opalin, a newly discovered marker for myelinating OLs (Golan et al., 2008; Jiang et al., 2013) .
Previous studies have shown that expression of constitutively active AKT in OLs increases mTORC1 activity and enhances myelination in the brain . This effect is reversed by the mTor inhibitor rapamycin (Narayanan et al., 2009) suggesting that the effect of AKT on myelination is mediated by mTor. Studies of cultured cells showed that rapamycin arrests the differentiation of OPCs at O4ϩ stage, suggesting a role of mTor in the early stage OPC differentiation (Tyler et al., 2009) . However, another report showed that inhibition of mTORC1 in cultured OLs only affects the late-stage transition of premyelinating OLs to fully matured OLs (Guardiola-Diaz et al., 2012) . In vivo ablation of mTor or Raptor (an essential component of mTORC1 complex) in OLs using CNP-Cre driver reveals a severe disruption in OL differentiation and myelination in spinal cord, but not in the brain, suggesting a region-dependent requirement of mTor or mTORC1 on OL and myelin formation in the CNS Wahl et al., 2014) . Thus, the role for mTORC1 signaling in OPCs versus OLs and its contribution to myelination in the brain remains unclear.
To address this challenge, we have used four different Cre lines to target Rheb1/mTORC1 activity in OPCs (Olig1-Cre, Olig2-Cre) and OLs (CNP-Cre, Tmem10-Cre). We targeted Rheb1 since it is essential for mTORC1 (Y. Li et al., 2004; Zou et al., 2011) and its neuronal expression can be naturally regulated by activity (Yamagata et al., 1994) . Rheb1 deletion in vivo in neural progenitor cells using Nestin-Cre driver, which results in reduction of mTORC1 in all types of neural cells, prevents OPC maturation and myelination (Zou et al., 2011) . We report that OL-intrinsic signaling of Rheb1 and mTor is essential for the early stage OPC differentiation to OLs in the brain, but Rheb1 is not required for the survival of OLs or generation and maintenance of myelin. tm9(CAG-tdTomato)Hze /J; The Jackson Laboratory) to validate Cre recombinase activity. Aldh1L1 knock-out mice were generated with a knockin/knock-out strategy by inserting eGFP-Cre cDNA into the locus right after the Aldh1L1 promoter in our lab. The insertion of eGFP-Cre cDNA disrupts the reading frame of Aldh1L1. All strains were on C57/BL/6 and 129s4 mixed backgrounds. Both males and females were used in all analyses. All mouse protocols were conducted in accordance with the guidelines set forth by Sichuan University and Johns Hopkins University.
Materials and Methods

Animals. Cre lines include
Antibodies. Phosphorylated-S6 (Ser240/244), total AKT, phosphorylated-AKT (Ser473), phosphorylated-4EBP (T37/46), and phosphorylated-histone3 (Ser10) antibodies were purchased from Cell Signaling Technology; Olig2, NG2, GFAP, MOG, and CNPase antibodies from Millipore; CC1 and MBP antibodies from Calbiochem; PDGFR␣ from Becton Dickinson; PLP, BrdU, and Ki67 from Abcam; and Iba-1 from Wako Chemicals. Rheb1 antibody was generated by immunizing New Zealand white rabbits with bacterial GST fusion protein (Zou et al., 2011) . Tmem10 antibody was generated by immunizing New Zealand white rabbits with bacterial His-tagged fusion protein . Aldh1L1 antibody was generated by immunizing New Zealand white rabbits with bacterial GST fusion protein (150 AA of mouse Aldh1L1 in C-terminal) in our lab.
Western blotting. Mice were rapidly decapitated and brains were removed. The brain was dissected into cortical, hippocampus, and cerebellum regions. To make cell extracts, tissues were homogenized in lysis buffer (2% SDS with proteinase inhibitors and phosphatase Inhibitor). The protein concentration of each extract was measured using the BCA Protein Assay kit (Thermo Scientific Pierce). Equal amounts of proteins from each extract were loaded into SDS-PAGE gel and blotted with various antibodies, according to standard Western blotting procedures. Western blotting and densitometry was performed using the ECL system (Thermo Scientific Pierce) and ImageJ.
Immunohistochemistry, histology, and electron microscopy. Tissues for immunohistochemistry and electron microscopy were prepared as described previously (Zou et al., 2011) . For electron microscopy, ultrathin sections were obtained using Ultracut UCT (Leica) and stained with 2% uranyl acetate and lead citrate. Electron micrographs were taken with a Hitachi electron microscope.
BrdU labeling and in situ hybridization. For OPC proliferation analysis, we injected mice intraperitoneally with BrdU (100 mg/kg; Sigma). Two hours later, the perfused brains were dissected out and brain cryosections were stained with anti-BrdU and anti-Olig2 antibodies to visualize proliferating OPCs. For cell-cycle exit experiment, mice were intraperitoneally injected with BrdU (100 mg/kg) and killed 24 -36 h later. The cell-cycle exit index was measured as the percentage of the OPCs that exited the cell cycle (BrdUϩ/Ki67Ϫ) divided by total BrdUϩ cells in the corpus callosum.
For in situ hybridization, brain sections were prepared the same way as with immunohistochemistry. Briefly, a probe for Plp was amplified using gene-specific PCR primers (Allen Institute for Brain Science, Seattle, WA) from mouse brain. The resulting fragment was cloned into pKSII transcription vectors. All the buffers were made with DEPC-treated water. In situ hybridization was then performed on sectioned tissue as described previously (Schaeren-Wiemers and Gerfin-Moser, 1993) . Brain sections were fixed in 4% buffered paraformaldehyde, treated with 0.5% acetic anhydride/1.5% triethanolamine, and equilibrated in PBS. After 1 h prehybridization at 65°C, DIG-UTP labeled Plp probe was added to each slide and hybridization was performed in a humidified box at 60°C for 16 h. Slides were washed to a final stringency of 0.2ϫ SSC at 60°C. Afterward, anti-DIG-alkaline phosphatase antibody (1:5000 BMB; catalog #1093274) was applied in blocking solution with 10% normal goat serum and 0.1% Triton X-100 in PBS and kept at 4°C overnight. Slides were washed and equilibrated in Tris-buffered saline (with 0.1% Tween 20) and developed in BM-Purple AP substrate (with 0.5 mg/ml levamisole, ) at room temperature in the dark. The reaction was terminated by washing in 1ϫ PBS, 0.1% Triton X-100, and then rinsed with distilled water, air dried, and mounted with antifade media (Invitrogen).
RNA extraction and RT-PCR. Total RNAs were extracted from tissues using TRIzol reagent (Invitrogen). RNA was subjected to reverse transcription with reverse transcriptase as Manufacturer's instructions (Fermentas). Quantitative real-time PCR was performed using the Bio-Rad CFX96 system, and the relative gene expression was normalized to internal control as gapdh. Primer sequences for SYBR Green probes of target genes are as follows: Mbp: ATCCAAGTACCTGGCCACAG and CCT-GTCACCGCTAAAGAAGC; Cnp: TTCTGGAGATGAACCCAAGG and TCTCTTCACCACCTCCTGCT; Plp: CTGGCTGAGGGCTTCTACAC and GACTGACAGGTGGTCCAGGT; Mog: AAATGGCAAGGACCAA-GATG and AGCAGGTGTAGCCTCCTTCA; Mobp: CATTTGCTTC-CCATTCACCT and AGGATGCCTCCATTTCCTCT; Tmem10: TGAGCCCGTAGAGGAGACT and CATATATGTGCCCTTCTTGG; Mag: TGGGCCTACGAAACTGTACC and GCTCCGAGAAGGTG-TACTGG; Gapdh: GGTGAAGGTCGGTGTGAACG and CTCGCTC-CTGGAAGATGGTG.
Cells counts. Three to four animals per genotype were used to examine the cellular marker expression for each time point. In the cortex, three to five nonadjacent sections were counted per animal. In the corpus callosum, images were acquired to include only the corpus callosum at the midline. Counts were statistically compared using Student's t test.
Statistical analysis. Data represent the mean and SEM. Student's t test (one-tailed for Western blot and qRT-PCR, two-tailed for the others) was performed for all statistical significance analysis using GraphPad Prism software. *p Ͻ 0.05, **p Ͻ 0.01, and ***p Ͻ 0.001.
Results
Hypomyelination in brain of the Rheb1
f/f ;Olig1 Cre؉/؊ mouse To examine the cell-intrinsic effect of Rheb1 on oligodendrogenesis, we crossed floxed Rheb1 mouse with Olig1-Cre deleter mouse (Lu et al., 2002) Creϩ/Ϫ mice (Fig. 1F,G) .
Creϩ/Ϫ mice showed severe hypomyelination in the corpus callosum, cortex, and striatum of the brain at P14 and P28 as indicated by Black Gold and MBP staining ( Fig. 1 B, C) . Electron microscopy further demonstrated reduced number of myelinated axons in the optic nerve of Rheb1 f/f ;Olig1 Creϩ/Ϫ mice (Fig. 1D) . In P28 controls, 58% of axons were myelinated, whereas only 25% of axons were myelinated in Rheb1 f/f ;Olig1 Creϩ/Ϫ (Fig. 1D ). In addition, the proportion of small-diameter axons (Ͻ1.0 m) was increased by 37%, whereas the large-diameter axons, particularly in the range of 1.0 -1.5 m, decreased by 26% (Fig. 1D) , suggesting that the axon diameter might be reduced in the Rheb1 f/f ;Olig1 Creϩ/Ϫ mice. The g-ratio of the remaining myelinated axons in Rheb1 f/f ;Olig1
Creϩ/Ϫ was comparable to that in controls (data not shown). Consistent with hypomyelination in the brain, the mRNA levels of myelin genes including myelin basic protein (Mbp), 2Ј3Ј cyclic nucleotide 3Ј-phosphodiesterase (Cnp), myelin oligodendrocyte glycoprotein (Mog), and Tmem10, were reduced in the cortex of Rheb1
Creϩ/Ϫ at P28 (Fig. 1E ). Corresponding myelin proteins were diminished in the brain from P28 (Fig. 1F ,G) to 8 months ( Fig. 1H,I ), indicating severe myelination deficit in the brain.
Reduced oligodendrogenesis in brain of the
Rheb1
f/f ;Olig1 Cre؉/؊ mouse To determine whether the observed hypomyelination was a consequence of impaired OPC differentiation, we analyzed expression of cellular markers for OPCs and differentiated OLs. The results showed that the total number of OL lineage cells indicated by Olig2ϩ cells was not significantly reduced ( p ϭ 0.1038); however, the number of differentiated OLs expressing markers CC1 and Olig2 (CC1ϩ/Olig2ϩ) cells was reduced by 54% compared with control ( Fig. 2 A, B) . In addition, expression of mature OL markers such as PLP and Tmem10 was diminished in the cortex of mutant at P14 and P28 ( Fig. 2C-F ). Tmem10 immunofluorescence reveals that the numbers of mature OLs and myelinated fibers are reduced in the cortex of Rheb1 f/f ; Olig1
Creϩ/Ϫ mice ( Fig. 2 E, F ) . In contrast to the reduction of differentiated OLs, the number of OPCs with PDGFR␣ϩ was significantly increased (Fig. 2G,H ) . These results indicate that Rheb1 contributes to the regulation of OPC differentiation to mature OLs in the brain. 
Reduced oligodendrogenesis and myelination in brain of the
Rheb1
f/f ;Olig2 Cre؉/؊ mouse The effect of Rheb1 deletion on OPC differentiation in the cortex and corpus callosum was reproduced in another Rheb1 conditional deletion mouse (Fig. 3) (Fig. 4 A, C; data not shown). The number of Plpϩ OLs in the P14 cortex appeared to be modestly reduced, but was not different from controls in the corpus callosum (Fig. 4 B, D ) mice (P4) with BrdU (100 mg/kg) for 2 h and found the number of proliferating OPCs (BrdUϩ/Olig2ϩ) was normal compared with that of controls (Fig. 5 A, B) . This suggests that Rheb1 is not required for the proliferation of OPCs. To test the possibility that loss of Rheb1 impairs cell-cycle exit of OPCs, we measured the cell-cycle exit index (Sanada and Tsai, 2005) . BrdU was injected into control and Rheb1 f/f ; Olig1 Creϩ/Ϫ mice at P4. After 24 -36 h, brains were collected and analyzed by immunohistochemistry with antiBrdU and anti-Ki67 (a marker for cells in active phases of the cell cycle-G 1 , S, G 2 , M) antibodies (Fig. 5C ). The total number of Ki67ϩ cells was not altered (Fig. 5D) Creϩ/Ϫ mice, and found that the number of P-H3ϩ/Olig2ϩ cells was reduced in the corpus callosum of Rheb1 f/f ;Olig1 Creϩ/Ϫ mice, compared with that in controls (Fig. 5 E, F ) . The reduction in the number of P-H3ϩ/Olig2ϩ cells in the corpus callosum is indicative of impaired G 2 /M progression in cell cycle. The above results suggest that Rheb1 contributes to the regulation of G 2 /M progression in cycling OPCs, such that deletion of Rheb1 in OPCs impairs their cycle exit and thus OPC differentiation.
Astrocyte formation in the brain not affected by Rheb1 deletion Because NG2ϩ OPCs are shown to generate both OLs and gray mater astrocytes (Zhu et al., 2008) , which can share a common progenitor in certain tissues (Rompani and Cepko, 2010), we examined if Rheb1 deletion reduces the formation of gray matter astrocytes, which may affect myelination in the cortex. Because GFAP antibody does not label gray matter astrocytes in the cortex, we generated Aldh1L1 antibody that recognizes both gray and white matter astrocytes in the brain; therefore, Aldh1L1 is a pan-astrocyte marker (Cahoy et al., 2008) . The Aldh1L1 antibody readily detected a band of expected 99 kDa protein in multiple brain tissues, which was absent in Aldh1L1 knock-out tissues (Fig. 6 A, B) . Immunostaining shows that it labels both gray matter astrocytes in the cortex and white matter astrocytes in corpus callosum ( Fig. 6C; data not shown) . In white matter, it labels the same astrocytes as GFAP antibody labels (data not shown). Using Aldh1L1 antibody, we found that the number of gray matter astrocytes in the cortex was normal in Rheb1 f/f ;Olig1 Creϩ/Ϫ mouse (Fig. 6 D, F ) . To further examine the effect of Rheb1 on astrocyte formation, we assayed the number of astrocytes in the brain of Rheb1 f/f ;Nestin Creϩ/Ϫ mouse, where Rheb1 was deleted in neural progenitors that give rise to neurons and glia. The results indicate Rheb1 is not essential for astrocyte formation (Fig. 6 E, F ) .
mTor deletion in OPCs phenocopies Rheb1 knock-out in the brain mTor functions in two complexes-mTORC1 and mTORC2 (Sarbassov et al., 2005a, b; Jacinto et al., 2006) . Our previous work confirmed that Rheb1 is required for mTORC1 activity in vivo (Zou et al., 2011) . To examine if mTor mediates the effect of Rheb1 on OL differentiation and myelination in the brain, we generated mTor conditional knock-out mice by breeding mTor f/f (Gangloff et al., 2004) Creϩ/Ϫ mice showed reduced Black Gold-positive myelinated fibers in the cortex, corpus callosum, and striatum in the brain at P28 (Fig. 7A ). MBP and Tmem10 staining similarly revealed lack of myelin in the cortical layers, cingulum bundles, and corpus callosum (Fig. 7 B, C) . Western blots and quantifications confirmed reduction of myelin proteins in the cortex and hippocampus of mTor f/f ;Olig1
Creϩ/Ϫ mice ( Fig. 7 D, E) . Consistent with the reduction in myelin proteins, mRNA expression of myelin genes was significantly reduced (Fig. 7F ). These observations indicate mTor f/f ; Olig1
Creϩ/Ϫ phenocopies Olig1-Cre-mediated Rheb1 deletion mice.
To determine whether the observed hypomyelination in mTor f/f ;Olig1 Creϩ/Ϫ mice was also a consequence of impaired OPC differentiation, we analyzed the numbers of differentiated OLs (CC1ϩ/Olig2ϩ) and OPCs (PDGFR␣ϩ/NG2ϩ) in mTor
Creϩ/Ϫ mice ( Fig. 8A-E) . Overall, the number of Olig2ϩ cells was comparable in the cortex and slightly reduced in the corpus callosum (*p ϭ 0.0389) compared with control (mTor f/ϩ ; Olig1
Creϩ/Ϫ ). There was a significant decrease in the number of OLs identified as CC1ϩ/Olig2ϩ cells in the cortex and corpus callosum ( Fig. 8A ; quantified in B; **p ϭ 0.0096, ***p ϭ 0.0007), Conversely, the number of OPCs indicated by PDGFR␣ and NG2 was increased in the cortex of mTor f/f ;Olig1 Creϩ/Ϫ mice ( Fig. 8C,E ; Creϩ/Ϫ mice (n ϭ 3, *p ϭ 0.0197, mean Ϯ SEM). (Fig.  8 D, F ; *p ϭ 0.0229). These data support the notion that Rheb1/ mTor controls myelination in the brain by regulating the differentiation OPCs to become OLs in the brain.
Myelin maintenance in the brain not affected by Rheb1 deletion in mature OLs
A previous study using CNP-Cre deletion of Raptor suggested that mTORC1 may be important for maintenance of myelin . As noted, CNP-Cre is expressed early in OL differentiation, which leaves open the possibility that it impacts OL differentiation independently of myelin maintenance. To address this question, we generated a Tmem10-Cre knockin mouse in which Cre cDNA was inserted into the open-reading frame of Tmem10. Tmem10-Cre activity was expressed in fully matured OLs, not in OPCs, astrocytes, or microglia as assessed by visualizing tdTomato (tdT) reporter (Madisen et al., 2010) Fig. 9 B, C) . This indicates that Rheb1 is not required for survival of mature OLs. To determine whether the expression of myelin proteins and myelin maintenance were affected in Rheb1 f/f ;Tmem10 Creϩ/Ϫ mice, we examined myelin proteins by Western blotting and myelin structure by electron microscopy at different time points compared with control mice. Representative Western blots and quantification revealed comparable expression of myelin proteins at P28 and 6 months ( Fig.  9 D, E) . MBP staining also revealed comparable patterns of myelin fibers in the cortex at P28 (Fig. 9F ) . No difference in myelin structure was observed in 5 month optic nerves between Rheb1 f/f ; Tmem10
Creϩ/Ϫ and control mice (Fig. 9G,H) . These results indicate that Rheb1 expression in mature OLs is not required for the synthesis or maintenance of myelin. (Fig. 10 A, B) . In addition, we found that the levels of myelin proteins were consistently reduced in the spinal cords of both Rheb1 f/f ;Olig1 Creϩ/Ϫ and Rheb1 f/f ;CNP Creϩ/Ϫ mice (Fig. 10C,D) . At P14, the reduction in myelin proteins was comparable between these two Rheb1 KO lines. At P28, myelin proteins remained reduced by ϳ50% in the spinal cord of 
Olig1
Creϩ/Ϫ mice, hypomyelination in the spinal cord appears to be caused by impairment in oligodendrogenesis since the number of differentiated OLs (Olig2ϩ/CC1ϩ) was reduced in both P14 and P28 spinal cord of Rheb1 f/f ;Olig1 Creϩ/Ϫ mice (Fig. 10E) . The total number of OL lineage cells (Olig2ϩ) was slightly reduced at P14 and P28, but not statistically significant. In the Rheb1 f/f ;CN-P Creϩ/Ϫ mouse, we found that differentiated OLs were reduced in P14 but recovered in P28 spinal cord (Fig. 10F ) . The total number of OLs was comparable to controls in both P14 and P28 spinal cord of Rheb1 f/f ;CNP Creϩ/Ϫ . These data indicated that deletion of Rheb1 in OPCs or OLs affects spinal cord OL differentiation and myelination. In addition, the effects of Rheb1 deletion from Olig1-Cre were more severe than CNP-Cre deletion in the spinal cord.
Discussion
Rheb1/mTor regulates early stage differentiation of OPCs in the brain and spinal cord Our study reveals that Rheb1 and mTor function in OPCs to regulate early stage OPC differentiation in the brain and spinal cord. Rheb1 is not required in mature OLs to make or maintain myelin. Rheb1/mTor-dependent defects in CNS myelination appear to be caused by failure to generate sufficient numbers of mature OLs, which are the source of myelin. The observation that Rheb1/mTor plays an essential yet selective role in OPCs to control their maturation identifies a critical nodal point in myelin biology. Our conclusions are based on comparisons of four Cre driver lines that span the OPC to mature OL lineage. Olig1-Cre and Olig2-Cre are the earliest, and Rheb1 excision in OPCs with these drivers markedly reduces the formation of OLs in the brain without disrupting OPC proliferation. The effect of Rheb1 on early stage OPC differentiation is mediated by mTor, because mTor deletion by Olig1-Cre leads to a similar degree of reduction in mature OLs and myelination in the brain as in Rheb1 f/f ; Olig1
Creϩ/Ϫ mouse. In contrast, CNP-Cre-mediated deletion of Rheb1 reduces OL formation and myelination selectively in the spinal cord, with minimal effects in the brain. This regional difference is consistent with reported results of CNP-Cre-mediated mTor and Raptor deletion Wahl et al., 2014) . One possible reason for this regional effect might be related to differential expression of CNP-Cre in subpopulations of OPCs. In the spinal cord, ventrally derived OPCs are generated in early waves of oligodendrogenesis and account for 85% OPCs in the spinal cord (Yu et al., 1994) . In the forebrain, ventrally derived OPCs and OLs are replaced by more dorsal precursors with each OPC pool contributing ϳ50% (Kessaris et al., . Accordingly, differences between spinal cord and brain might be explained if floxed Rheb1 (or mTor/Raptor) were not be recombined as efficiently in the cortex/dorsal-derived OPCs. The differential action of these Cre drivers suggests that there is a narrow developmental time window in early stage differentiation of OPCs in brain during which Rheb1/mTor function is required.
Rheb1/mTORC1 is not required for myelin gene/protein expression and myelin maintenance
Tmem10-Cre is expressed in mature OLs and cleanly excludes a requirement for Rheb1 in myelination or myelin gene expression in these cells. Results from the Tmem10-Cre-mediated Rheb1 knock-out mouse indicate that mTor (TORC1)-dependent regulation of OPC differentiation is not through the control of myelin gene transcription or myelin protein synthesis. Regulated expression of myelin genes is an important aspect of myelin formation, and transcription of multiple myelin genes is upregulated in close correlation with OPC maturation. The finding that rapamycin elevates the expression of negative transcription factors of OL differentiation suggests that mTORC1 regulates OL differentiation through transcriptional control of early stage OPC differentiation . In support of this model, knockdown of mTORC1 activity by means of siRNA to Raptor reduces MBP protein in cultured OLs and suggests that mTORC1 may regulate OPC differentiation in a coordinated or closely hierarchical fashion with myelin protein synthesis (Tyler Li et al., 2006; Chaveroux et al., 2013) and protein synthesis (Bilanges et al., 2007; Thoreen et al., 2012) in other cell types. However, deletion of Rheb1 in mature OLs by Tmem10-Cre driver does not affect the number of mature OLs or expression of myelin gene mRNAs and proteins. The normal number of mature OLs and expression of mRNA and protein of myelin genes and myelination in the brain of Rheb1 f/f ; Tmem10
Creϩ/Ϫ mice as old as 6 months suggests that Rheb1/ mTORC1 is not essential for the sustained expression of myelin genes, myelin turnover, or maintenance. This highlights the notion that Rheb1/mTORC1-dependent OPC differentiation to OL is a distinct process from control of myelin gene expression. The observation that Rheb1 is not required in mature OLs for myelin expression is surprising since mTORC1 plays an integrative role in energy metabolism and lipid synthesis (Cunningham et al., 2007; Peterson et al., 2011) , both of which are required for myelin membrane synthesis (Stevens et al., 2002; Verheijen et al., 2009; Rinholm et al., 2011; Wake et al., 2011) .
A recent study shows a modest increase in g-ratio of spinal cord axons of Raptor knock-out mouse, suggesting a modest impairment in myelin maintenance and more pronounced increase in g-ratio in Raptor/Rictor double knock-out mouse, one year after the deletion of corresponding genes in mature OLs (LebrunJulien et al., 2014) . The enhanced impairment in myelin maintenance may suggest an involvement of mTORC2 activity in myelin maintenance. mTORC2 activity as indicated in pAKT (S473) was found to be increased in the brain of Rheb1 knock-out mouse, which may also be attributable to normal myelin maintenance.
Rheb1/mTORC1 regulates cell-cycle exit of OPCs
The effect of mTORC1 activity on OPC differentiation is likely through the control of cell-cycle exit, because reduced cell-cycle exit of OPCs is present both in Olig1-Cre-mediated Rheb1 and mTor knock-out mice. The reduced cell-cycle exit of OPCs seems to be due to impairment in G 2 /M progression. The effect of Rheb1 deletion on G 2 /M progression is consistent with previous report showing that inhibition of mTORC1 activity by rapamycin impairs growth factor-stimulated G 2 /M progression of cultured OPCs (Min et al., 2012) . The notion that Rheb1/mTORC1 regulates OPC differentiation through its effect on cell-cycle exit is also supported by other studies. Magri et al. (2014) reported that the time course of cell-cycle exit coincides with the initiation of differentiation toward myelinating phenotypes, i.e., expression of myelin genes and the decline in the cell-cycle regulator-E2F1 transcription factor, while genetic ablation of the inhibitor gene coding for cyclin-dependent kinase p27Kip1 impairs the differentiation of OPCs to mature OLs (Casaccia-Bonnefil et al., 1997) . Our results indicate that OPCs are capable of proliferation in absence of Rheb1/mTor since OPC numbers increase simultaneously with reduced OL generation. The remarkably restricted requirement for mTORC1 is consistent with previous observations. For example, Rheb1 deletion in neural progenitor cells using Nestin-Cre does not prevent formation of neurons, astrocytes, or OPCs (Zou et al., 2011) , nor is it required for Schwann cell formation in the peripheral nervous system (data not shown). Similar findings are noted for non-neural cell types, such as T-lineage lymphocytes, where Rheb1/mTORC1 selectively affects the formation of a subtype of T-lymphocytes (Delgoffe et al., 2009 ). Thus, while mTORC1 can regulate many aspects of cellular function, it appears to be required for rather distinct aspects of cell biology that varies between cell types. This may rationalize the therapeutic value of modifiers of the mTor pathway.
In summary, our analysis of OL lineage Rheb1 and mTor knock-out mice indicates that OL-intrinsic mTORC1 activity regulated by Rheb1 plays a critical role in the formation of mature OLs, which in turn are response for generation of myelin. There is a narrow time window during which mTORC1 is essential for early stage differentiation of OPCs. Rheb1/mTORC1 is not critical for the expression of most myelin genes in differentiated OLs or essential for the maintenance of myelin in the brain. Our study clarifies the essential role of OPC-intrinsic Rheb1/mTORC1 activity in myelin program in the brain.
